Targeting Ovarian Cancer Cells Overexpressing CD44 with Immunoliposomes Encapsulating Glycosylated Paclitaxel

Paclitaxel (PTX) is one of the front-line drugs approved for the treatment of ovarian cancer. However, the application of PTX is limited due to the significant hydrophobicity and poor pharmacokinetics. We previously reported target-directed liposomes carrying tumor-selective conjugated antibody and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Khayrani, Apriliana Cahya, Mahmud, Hafizah, Oo, Aung Ko Ko, Zahra, Maram H., Oze, Miharu, Du, Juan, Alam, Md Jahangir, Afify, Said M., Quora, Hagar A. Abu, Shigehiro, Tsukasa, Calle, Anna Sanchez, Okada, Nobuhiro, Seno, Akimasa, Fujita, Koki, Hamada, Hiroki, Seno, Yuhki, Mandai, Tadakatsu, Seno, Masaharu
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429518/
https://ncbi.nlm.nih.gov/pubmed/30818864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20051042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados